Funded Biotechnology Startups in Finland
Among the 25 most recent biotech rounds listed for Finland, Solar Foods’ $46M (2026-06-17) is the only disclosed round above $40M and it dwarfs the next-la…
Among the 25 most recent biotech rounds listed for Finland, Solar Foods’ $46M (2026-06-17) is the only disclosed round above $40M and it dwarfs the next-largest disclosed amounts: FinVector’s $48M (2023-06-07) is comparable on the high end, while several other large rounds cluster at $30M–$21M (e.g., Infinited Fiber Company $30M on 2024-03-08; Onego Bio $29M on 2024-04-02; Algorithmiq $21M on 2026-05-11). The smallest disclosed amount is the $60K round for Eevia Health on 2024-08-29, creating a wide disclosed range from $60K to $48M.
Geographically, Helsinki and the wider “Southern Finland” footprint dominate: multiple Helsinki-based entries appear across 2021–2026 (Solar Foods; Nanoform; Valo Therapeutics; Nexstim; Onego Bio; Herantis Pharma), with Espoo showing repeated activity (NPHarvest, Enifer, Origin by Ocean, Infinited Fiber Company, Desentum). Temporally, rounds are concentrated in the latest year of listings (2026-01-20 to 2026-06-17 includes four entries, including $46M on 2026-06-17 and $21M on 2026-05-11), with the oldest row dated 2021-06-10 (Brinter). Stage labeling is also uneven: five entries carry “Series Unknown” and three are explicitly labeled undisclosed (Thermidas 2023-06-06; NADMED 2022-10-04), alongside multiple seed/pre-seed rounds (e.g., Solu pre-seed $1M on 2023-06-15; Measurlabs seed $3M on 2023-09-01).
Most recent rounds
25 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Finland biotech set, and how extreme is it versus the rest?
FinVector’s $48M on 2023-06-07 is the largest disclosed amount in the 25-row view, and it sits above several other top disclosed rounds like Solar Foods’ $46M (2026-06-17), Infinited Fiber Company’s $30M (2024-03-08), and Onego Bio’s $29M (2024-04-02). At the low end, Eevia Health’s $60K on 2024-08-29 is the smallest disclosed amount, widening the spread substantially.
Which locations appear over-represented, and do they cluster around specific cities like Helsinki or Espoo?
Helsinki and its metro area dominate the repeated pattern: Helsinki-based names include Solar Foods (Helsinki, 2026-06-17), Nanoform (Helsinki, 2025-06-19), Valo Therapeutics (Helsinki, 2025-03-10), Nexstim (Helsinki, 2024-06-27), Herantis Pharma (Helsinki, 2025-02-06), and Onego Bio (Helsinki, 2024-04-02). Espoo shows a separate concentration with NPHarvest (2026-01-20, $1M), Enifer (2024-05-23, $16M), Origin by Ocean (2023-04-26, $5M), Infinited Fiber Company (2024-03-08, $30M), and Desentum (2024-02-08, $13M).
Is there a tight recency window where multiple rounds closed, or are dates evenly spread?
Dates skew toward recent activity: in 2026 alone, there are four entries between 2026-01-20 (NPHarvest, $1M) and 2026-06-17 (Solar Foods, $46M). The 2023–2024 period also shows repeated clustering at higher amounts, including FinVector ($48M on 2023-06-07), Onego Bio ($29M on 2024-04-02), and Infinited Fiber Company ($30M on 2024-03-08).
How does stage labeling break down, and are early-stage rounds a consistent theme?
While many entries use “Series Unknown” (5 rows: Solar Foods 2026-06-17 through Herantis Pharma 2025-02-06, plus others in 2026–2024), early-stage labels still appear repeatedly: Seed rounds include StemSight ($2M, 2025-02-13), Resistomap ($2M, 2023-11-15), and Measurlabs ($3M, 2023-09-01). Pre-seed is also present via Solu ($1M, 2023-06-15), and at least two later labeled rounds show up such as Enifer (Series B, $16M on 2024-05-23) and Onego Bio (Series A, $29M on 2024-04-02).
Are there notable outliers where disclosed size doesn’t match the surrounding pattern or where amounts are missing?
Size outliers are clear at both ends: Eevia Health’s $60K (2024-08-29) is dramatically smaller than the next-low disclosed amounts like Finnadvance’s $1M (2022-04-08) and Solu’s $1M (2023-06-15), while Solar Foods’ $46M (2026-06-17) is far above many mid-tier rounds such as NPHarvest’s $1M (2026-01-20). Separately, disclosure gaps exist: Thermidas ($undisclosed, 2023-06-06) and NADMED ($undisclosed, 2022-10-04) prevent direct comparisons for those two entries.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.